Clinician Decision Making Regarding Surveillance for Low-risk Intraductal Papillary Mucinous Neoplasms of The Pancreas
Completed
- Conditions
- Surgery Risk Assessment
- Registration Number
- NCT06311032
- Lead Sponsor
- NYU Langone Health
- Brief Summary
The main objective of this study is to determine how physicians make decisions regarding surveillance of Intraductal Papillary Mucinous Neoplasm's (IPMN) of the pancreas.
- Detailed Description
The study will employ a survey design that poses physicians with a series of three clinical case vignettes. Each vignette describes an IPMN of varying severity, and the physician will be asked determine whether they would continue or discontinue clinical surveillance in each case.
This will be a double-blinded randomized survey study, featuring two arms. Providers will be randomized to either be provided with, or not provided with a risk stratification tool (DART-1) when presented with their clinical case vignettes.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 72
Inclusion Criteria
- Membership in either the PACYFIC or PRECEDE consortiums
- Physician with expertise in the management of IPMN
- Able and willing to complete survey
Exclusion Criteria
- Not a member of either the PACYFIC or PRECEDE consortiums
- Not a physician with expertise in the management of IPMN
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Number of Decisions to Stop Surveillance Imaging Day 1 Number of Decisions to Continue Surveillance Imaging Day 1
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
NYU Langone Health
🇺🇸New York, New York, United States